Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

Standardizing PRP therapy practices and regulations in Europe is crucial for safe and effective treatment.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

BB4CMU rice bran oil may help treat hair loss and gray hair.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Baricitinib reduces inflammation and improves cell health in premature aging cells.

The patch effectively promotes hair growth for alopecia areata without pain.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

The document sets guidelines to standardize reporting of PRP clinical trials for better reproducibility and comparability.

Early recognition of skin lesions in Birt-Hogg-Dubé syndrome is crucial for detecting renal tumors early.

Certain cancer drugs can cause skin issues like rashes and itching.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Berberine may reduce prostate enlargement by blocking inflammation.

Shi-Bi-Man helps hair regrowth by activating the FGF pathway in cells.

The Hr protein binds to DNA, interacts with p53, and affects cell cycle genes.